Sort
48,018 grants matching “immunotherapy”
The Unique Roles of Tumor-Specific Th9 Cells for Solid Tumor Eradication
$376,900Yong Lu · Methodist Hospital Research Institute · R01 · FY2024 · CA
Mechanistic investigations of microbiome-driven aryl hydrocarbon receptor activity and macrophage function in pancreatic cancer.
$376,878Tracy L McGaha · University Health Network · R01 · FY2021 · CA
T cell homing to the kidney contributes to salt retention and blood pressure regulation
$376,875Shengyu Mu · Univ Of Arkansas For Med Scis · R01 · FY2019 · HL
Intravital assessment of Borrelia burgdorferi immune clearance in skin
$376,808Ronald Mark Wooten · University Of Toledo Health Sci Campus · R01 · FY2017 · AI
Intravital assessment of Borrelia burgdorferi immune clearance in skin
$376,808Ronald Mark Wooten · University Of Toledo Health Sci Campus · R01 · FY2019 · AI
Intravital assessment of Borrelia burgdorferi immune clearance in skin
$376,808Ronald Mark Wooten · University Of Toledo Health Sci Campus · R01 · FY2020 · AI
Targeting Kidney Cancer-associated CD105 expression with a novel Listeria-based Vaccine Approach
$376,776Laurence Michael Wood · Texas Tech University Health Scis Center · R15 · FY2017 · CA
Role of Toll-like Receptor 9 in Fibroblastic Reticular Cell-based Therapy for Intra-abdominal Sepsis
$376,771Meihong Deng · Ohio State University · R01 · FY2021 · AI
HSP 110 and its role in cancer therapy
$376,769John R. Subjeck · Roswell Park Cancer Institute Corp · R01 · FY2010 · CA
Bile acids restrict functional reprogramming of myeloid-derived suppressor cells in tumor beds
$376,751Paulo Cesar Rodriguez · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
Role of Sirt2 in T Cell Metabolism
$376,751Sungjune Kim · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2022 · CA
Characterizing oncogenic function of ITCH in melanoma
$376,751Lixin Wan · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA
Bile acids restrict functional reprogramming of myeloid-derived suppressor cells in tumor beds
$376,751Paulo Cesar Rodriguez · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA
Role of Sirt2 in T Cell Metabolism
$376,751Sungjune Kim · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2021 · CA
PATHOGENESIS OF C NEOFORMANS PERSISTENCE
$376,688Yeshiva University · R01 · FY2001 · HL
Functions of Hopx in immune tolerance in a model of Multiple Sclerosis
$376,669Daniel Hawiger · Saint Louis University · R01 · FY2014 · AI
Clinical study of GMCI in Pancreatic Cancer
$376,666Estuardo Aguilar-Cordova · Advantagene, Inc · R43 · FY2007 · CA
Follicular Regulatory T-cells Promote Cancer
$376,659Jianmei Wu Leavenworth · University Of Alabama At Birmingham · R01 · FY2024 · CA
Project 1: Targeting the PD-1 pathway in HCC
$376,652Ahmed Kaseb · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
Project 1: Targeting the PD-1 pathway in HCC
$376,652Ahmed Kaseb · University Of Tx Md Anderson Can Ctr · P50 · FY2023 · CA
Project 1: Targeting the PD-1 pathway in HCC
$376,651Ahmed Kaseb · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
Alpha-Particle Immunotherapy of Cancer
$376,650Sloan-Kettering Institute For Cancer Res · R01 · FY2005 · CA
Angiogenic Factors Associated with Uveal Melanoma
$376,608Arthur S Polans · University Of Wisconsin-Madison · R01 · FY2007 · CA
Functions of Hopx in immune tolerance in a model of Multiple Sclerosis
$376,607Daniel Hawiger · Saint Louis University · R01 · FY2015 · AI
Preclinical Study of Peptide Based Human Tumor Vaccines
$376,597University Of Virginia Charlottesville · R01 · FY2004 · CA